Active substance
Results for the substance indacaterol+glycopyronium
1 result
About this active substance
The combination of indacaterol and glycopyrronium is used to treat chronic obstructive pulmonary disease (COPD). Indacaterol is a long-acting beta-2 adrenergic agonist, and glycopyrronium is a muscarinic antagonist, both working to relax airway muscles and improve lung function.
The medication is administered via inhalation, usually once daily, as directed by a doctor.
Side effects may include cough, dry mouth, headache, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.
Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
The medication is administered via inhalation, usually once daily, as directed by a doctor.
Side effects may include cough, dry mouth, headache, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.
Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.